These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 23931623)
1. Synthesis of transition-metal steroid derivatives. Le Bideau F; Dagorne S Chem Rev; 2013 Oct; 113(10):7793-850. PubMed ID: 23931623 [No Abstract] [Full Text] [Related]
2. Synthesis, molecular structure and evaluation of new organometallic ruthenium anticancer agents. Camm KD; El-Sokkary A; Gott AL; Stockley PG; Belyaeva T; McGowan PC Dalton Trans; 2009 Dec; (48):10914-25. PubMed ID: 20023922 [TBL] [Abstract][Full Text] [Related]
3. The Application of Reversible Intramolecular Sulfonamide Ligation to Modulate Reactivity in Organometallic Ruthenium(II) Diamine Complexes. Kemp SA; Prior TJ; Savoie H; Boyle RW; Murray BS Molecules; 2020 Jan; 25(2):. PubMed ID: 31936104 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a ruthenium(III)/NAMI-A adduct with bovine serum albumin that exhibits a high anti-metastatic activity. Liu M; Lim ZJ; Gwee YY; Levina A; Lay PA Angew Chem Int Ed Engl; 2010 Feb; 49(9):1661-4. PubMed ID: 20127775 [No Abstract] [Full Text] [Related]
5. Synthesis, structure and biological evaluation of bis salicylaldehyde-4(N)-ethylthiosemicarbazone ruthenium(iii) triphenylphosphine. Prabhakaran R; Kalaivani P; Jayakumar R; Zeller M; Hunter AD; Renukadevi SV; Ramachandran E; Natarajan K Metallomics; 2011 Jan; 3(1):42-8. PubMed ID: 21132183 [TBL] [Abstract][Full Text] [Related]
6. Ruthenium(II/III)-based compounds with encouraging antiproliferative activity against non-small-cell lung cancer. Nagy EM; Pettenuzzo A; Boscutti G; Marchiò L; Dalla Via L; Fregona D Chemistry; 2012 Nov; 18(45):14464-72. PubMed ID: 23012112 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands. Łakomska I; Fandzloch M; Muzioł T; Lis T; Jezierska J Dalton Trans; 2013 May; 42(17):6219-26. PubMed ID: 23328694 [TBL] [Abstract][Full Text] [Related]
9. RNA binding and inhibition of primer extension by a Ru(III)/Pt(II) metal complex. Jain SS; Anderson CM; DiRienzo F; Taylor IR; Jain K; Guha S; Hoque N Chem Commun (Camb); 2013 Jun; 49(44):5031-3. PubMed ID: 23615723 [TBL] [Abstract][Full Text] [Related]
10. Factors that influence the antiproliferative activity of half sandwich Ru(II)-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives. Rilak A; Bratsos I; Zangrando E; Kljun J; Turel I; Bugarčić ŽD; Alessio E Dalton Trans; 2012 Oct; 41(38):11608-18. PubMed ID: 22903512 [TBL] [Abstract][Full Text] [Related]
11. Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology? Nardon C; Brustolin L; Fregona D Future Med Chem; 2016; 8(2):211-26. PubMed ID: 26807601 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of ligational behavior of curcumin drug towards some transition metal ions: chelation effect on their thermal stability and biological activity. Refat MS Spectrochim Acta A Mol Biomol Spectrosc; 2013 Mar; 105():326-37. PubMed ID: 23318777 [TBL] [Abstract][Full Text] [Related]
13. Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents. Ludwig G; Kaluđerović GN; Rüffer T; Bette M; Korb M; Block M; Paschke R; Lang H; Steinborn D Dalton Trans; 2013 Mar; 42(11):3771-4. PubMed ID: 23340605 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterisation and biological activities of [(p-cym)RuX(pz4lut)]n+ and [{(p-cym)RuX}2(μ-pz4lut)]n+ (X = Cl, H2O and pz4lut = α,α,α',α'-tetra(pyrazol-1-yl)-2,6-lutidine). Tripathy SK; Surada RK; Manne RK; Mobin SM; Santra MK; Patra S Dalton Trans; 2013 Oct; 42(39):14081-91. PubMed ID: 23938874 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiproliferative activity of the heterobimetallic complexes [RuClCp(PPh₃)-μ-dmoPTA-1κP:2κ²N,N'-MCl₂] (M = Co, Ni, Zn; dmoPTA = 3,7-dimethyl-1,3,7-triaza-5-phosphabicyclo[3.3.1]nonane). Serrano-Ruiz M; Aguilera-Sáez LM; Lorenzo-Luis P; Padrón JM; Romerosa A Dalton Trans; 2013 Aug; 42(31):11212-9. PubMed ID: 23807438 [TBL] [Abstract][Full Text] [Related]
16. From catalysts to bioactive organometallics: do Grubbs catalysts trigger biological effects? Oehninger L; Alborzinia H; Ludewig S; Baumann K; Wölfl S; Ott I ChemMedChem; 2011 Dec; 6(12):2142-5. PubMed ID: 21901835 [No Abstract] [Full Text] [Related]
17. Design, synthesis and biological evaluation of novel estrogen-derived steroid metal complexes. Zhang X; Zuo Z; Tang J; Wang K; Wang C; Chen W; Li C; Xu W; Xiong X; Yuntai K; Huang J; Lan X; Zhou HB Bioorg Med Chem Lett; 2013 Jul; 23(13):3793-7. PubMed ID: 23726343 [TBL] [Abstract][Full Text] [Related]
18. Designing metal-free catalysts by mimicking transition-metal pincer templates. Lu G; Li H; Zhao L; Huang F; Schleyer Pv; Wang ZX Chemistry; 2011 Feb; 17(7):2038-43. PubMed ID: 21294173 [No Abstract] [Full Text] [Related]
19. A platform for on-the-complex annulation reactions with transient aryne intermediates. Chari JV; Spence KA; Susick RB; Garg NK Nat Commun; 2021 Jun; 12(1):3706. PubMed ID: 34140488 [TBL] [Abstract][Full Text] [Related]